Jove
Visualize
Contact Us

Related Concept Videos

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

467
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
467
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

6.0K
At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
6.0K
Anatomy of the Eyeball01:20

Anatomy of the Eyeball

7.1K
The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
7.1K
The Retina01:32

The Retina

69.0K
The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
69.0K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

181
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
181
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
  1. Home
  2. Alzheimer's Disease Pathophysiology In The Retina.
  1. Home
  2. Alzheimer's Disease Pathophysiology In The Retina.

Related Experiment Video

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.6K

Alzheimer's disease pathophysiology in the Retina.

Bhakta Prasad Gaire1, Yosef Koronyo1, Dieu-Trang Fuchs1

  • 1Department of Neurosurgery, Maxine Dunitz Neurosurgical Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.

Progress in Retinal and Eye Research
|May 17, 2024

View abstract on PubMed

Summary
This summary is machine-generated.

The retina shows Alzheimer

Keywords:
Alzheimer's diseaseInflammationNeurodegenerative diseasesRetinal imagingRetinal vascular pathologyVisual impairments

More Related Videos

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

10.6K
Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina
09:03

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina

Published on: February 13, 2021

4.3K

Related Experiment Videos

Using Retinal Imaging to Study Dementia
09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

21.6K
In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma
12:48

In Vivo Dynamics of Retinal Microglial Activation During Neurodegeneration: Confocal Ophthalmoscopic Imaging and Cell Morphometry in Mouse Glaucoma

Published on: May 11, 2015

10.6K
Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina
09:03

Transpupillary Two-Photon In Vivo Imaging of the Mouse Retina

Published on: February 13, 2021

4.3K

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Biomarkers

Background:

  • Alzheimer's disease (AD) pathology, including amyloid-beta (Aβ) deposits and tau, is found in the retinas of patients.
  • Retinal vascular abnormalities, inflammation, and neurodegeneration are observed in mild cognitive impairment and AD dementia.
  • Retinal and brain pathologies in AD show corresponding severity and patterns.

Purpose of the Study:

  • To explore the retina as a potential site for noninvasive diagnosis and tracking of Alzheimer's disease.
  • To investigate the correlation between retinal and brain pathologies in Alzheimer's disease.
  • To assess the utility of ophthalmic imaging for detecting AD hallmarks in the retina.

Main Methods:

  • Histological, biochemical, and clinical studies were used to analyze retinal and brain tissues.
  • Proteomics analysis compared protein expression patterns in the retina and brain of AD patients.
  • Investigational ophthalmic imaging technologies were employed to detect AD-specific changes in the retina.
  • Main Results:

    • Proteomics revealed similar dysregulated pathways in the retina and brain, including inflammation, neurodegeneration, and mitochondrial dysfunction.
    • Ophthalmic imaging can detect AD-specific amyloid deposits, vasculopathy, and neurodegeneration in living patients.
    • Retinal alterations correlate with disease stage and brain pathology.

    Conclusions:

    • The retina serves as a viable CNS target for Alzheimer's disease diagnosis and monitoring.
    • Ophthalmic imaging modalities show promise for clinical assessment of AD.
    • Further research with larger cohorts and standardized techniques is needed to validate retinal biomarkers for AD.